Cardiff Lexington CEO Alex Cunningham joined Steve Darling from Proactive to discuss the company’s transformation into an acquisition-oriented healthcare firm with a focus on orthopedic surgery centers.

Cardiff Lexington’s revenue primarily stems from bodily injury and general liability insurance coverages, providing insulation from pricing downsides associated with Medicare and Medicaid.

Cunningham emphasized the unique accounts receivable structure of the company, along with its focus on uninsured coverages, which contribute to maintaining high collectability rates. He also highlighted the increasing demand for orthopedic services driven by an aging population, positioning Cardiff Lexington for growth in this market.

The company’s recent financial performance showed significant increases in revenue, net earnings, and assets, reflecting its strategic focus and operational efficiency. Looking ahead to 2024, Cardiff Lexington plans to continue its expansion through acquisitions, market expansion initiatives, and strategic partnerships.

Furthermore, Cunningham mentioned the company’s plans to release its 10k in early March and pursue an uplift to a major exchange in 2024, with a clear focus on enhancing shareholder value and achieving strategic growth objectives.

Contact Details

Proactive North America

Proactive North America

+1 604-688-8158

[email protected]